Recently Updated
Corporate Spotlight
BlinkLab Limited (ASX: BB1) is a trailblazer in digital healthcare, leveraging AI and machine learning in mobile applications to revolutionise neurodevelopmental condition diagnosis like ASD and ADHD.
View the full Corporate Spotlight
WEBINAR REPLAY: BLINKLAB
Announcements
Filter Results
BB1 | Investor Presentation | 02/05/24 | ||
BB1 | BlinkLab Partnership with Turning Pointe Autism Foundation | 02/05/24 | ||
BB1 | Becoming a substantial holder | 09/04/24 | ||
BB1 | Becoming a substantial holder | 09/04/24 | ||
BB1 | Becoming a substantial holder | 09/04/24 | ||
BB1 | Becoming a substantial holder | 09/04/24 | ||
BB1 | Initial Director's Interest Notice x4 | 08/04/24 | ||
BB1 | Investor Presentation | 04/04/24 | ||
BB1 | Investor Webinar | 03/04/24 | ||
BB1 | BlinkLab to List on the ASX | 03/04/24 | ||
BB1 | Pre-Quotation Disclosure | 02/04/24 | ||
BB1 | Top 20 holders | 02/04/24 | ||
BB1 | Distribution schedule | 02/04/24 | ||
BB1 | Securities Trading Policy | 02/04/24 | ||
BB1 | Employee Securities Incentive Plan | 02/04/24 | ||
BB1 | Interim accounts to 31 December 2023 | 02/04/24 | ||
BB1 | Financial Accounts to 30 June 2023 | 02/04/24 | ||
BB1 | Financial Accounts to 30 June 2022 | 02/04/24 | ||
BB1 | Constitution | 02/04/24 | ||
BB1 | Replacement Prospectus | 02/04/24 | ||
BB1 | Appendix 1A and Information Form and Checklist | 02/04/24 | ||
BB1 | ASX Notice - Admission and Quotation | 02/04/24 | ||